These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 2363101

  • 1. [Bone marrow biopsy in myeloproliferative syndromes: prognostic value of cellular quantification].
    Esquivias López-Cuervo JJ, Romero Aguilar A, González García J.
    Sangre (Barc); 1990 Apr; 35(2):98-101. PubMed ID: 2363101
    [Abstract] [Full Text] [Related]

  • 2. [Bone-marrow biopsy in chronic myeloid leukemia. Value of the initial examination].
    Devred C, Bentata J, Diebold J, Bernadou A, Bilski-Pasquier G.
    Sem Hop; 1977 Jan 09; 53(2):119-24. PubMed ID: 189424
    [Abstract] [Full Text] [Related]

  • 3. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A.
    Pathobiology; 2007 Jan 09; 74(2):97-114. PubMed ID: 17587881
    [Abstract] [Full Text] [Related]

  • 4. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R, Marzetta K, Miglioranza A, Redaelli S, Maino C, Maffiolini A, Gorini M.
    Recenti Prog Med; 2003 Jan 09; 94(7-8):314-20. PubMed ID: 12868237
    [Abstract] [Full Text] [Related]

  • 5. [Histopathologic characteristics of bone marrow in patients with aplastic anemia].
    Milosević R, Janković G, Antonijević N, Jovanović V, Babić D, Colović M.
    Srp Arh Celok Lek; 2000 Jan 09; 128(5-6):200-4. PubMed ID: 11089422
    [Abstract] [Full Text] [Related]

  • 6. Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression.
    Panteli K, Zagorianakou N, Bai M, Katsaraki A, Agnantis NJ, Bourantas K.
    Eur J Haematol; 2004 Jun 09; 72(6):410-5. PubMed ID: 15128419
    [Abstract] [Full Text] [Related]

  • 7. Clinical and prognostic evaluation of bone marrow infiltration (biopsy versus aspirate) in early chronic lymphocytic leukemia. A single center study.
    Molica S, Tucci L, Levato D, Docimo C.
    Haematologica; 1997 Jun 09; 82(3):286-90. PubMed ID: 9234573
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Emperipolesis in megakaryocytes in patients with thrombocytosis in the course of myeloproliferative disorders].
    Bobik R, Podolak-Dawidziak M, Kiełbiński M, Jeleń M, Wróbel T.
    Acta Haematol Pol; 1995 Jun 09; 26(2):179-83. PubMed ID: 7653223
    [Abstract] [Full Text] [Related]

  • 10. [Jamshidi biopsy in clinical hematology. Method, indications and results of over 1,000 completed biopsies with special reference to chronic myeloproliferative diseases].
    Seewann HL.
    Wien Med Wochenschr Suppl; 1986 Jun 09; 100():1-24. PubMed ID: 3471009
    [Abstract] [Full Text] [Related]

  • 11. Bone marrow in megakaryocytic disorders.
    Burkhardt R.
    Hematol Oncol Clin North Am; 1988 Dec 09; 2(4):695-733. PubMed ID: 3065325
    [Abstract] [Full Text] [Related]

  • 12. Histopathological trephine biopsy findings in cases of 'dry tap' bone marrow aspirations.
    Navone R, Colombano MT.
    Appl Pathol; 1984 Dec 09; 2(5):264-71. PubMed ID: 6545669
    [Abstract] [Full Text] [Related]

  • 13. [LAT (linker for activation of T cells): a useful marker for megakaryocyte evaluation on bone marrow biopsies].
    Ungari M, Pellegrini W, Borlenghi E, Marocolo D, Ubiali A, Agazzi C, Pich A, Franco V, Facchetti F.
    Pathologica; 2002 Dec 09; 94(6):325-30. PubMed ID: 12540999
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of bone marrow biopsy in essential thrombocythemia.
    Annaloro C, Lambertenghi Deliliers G, Oriani A, Pozzoli E, Lambertenghi Deliliers D, Radaelli F, Faccini P.
    Haematologica; 1999 Jan 09; 84(1):17-21. PubMed ID: 10091388
    [Abstract] [Full Text] [Related]

  • 15. Bone marrow biopsy of aplastic anemia, myelodysplastic syndromes and myeloproliferative disorders.
    Kikuchi M.
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec 09; 51(8):1339-46. PubMed ID: 3247814
    [No Abstract] [Full Text] [Related]

  • 16. Megakaryopoiesis in chronic myeloproliferative diseases. A morphometric evaluation with special emphasis on primary thrombocythemia.
    Thiele J, Funke S, Holgado S, Choritz H, Georgii A.
    Anal Quant Cytol; 1984 Sep 09; 6(3):155-67. PubMed ID: 6594964
    [Abstract] [Full Text] [Related]

  • 17. Bone marrow mast cell morphologic features and hematopoietic dyspoiesis in systemic mast cell disease.
    Stevens EC, Rosenthal NS.
    Am J Clin Pathol; 2001 Aug 09; 116(2):177-82. PubMed ID: 11488063
    [Abstract] [Full Text] [Related]

  • 18. Detection of haematologic and nonhaematologic cancer by bone biopsy.
    Burkhardt R, Frisch B, Bartl R, Kettner G, Schlag R, Hill W.
    Cancer Detect Prev; 1981 Aug 09; 4(1-4):619-27. PubMed ID: 7349829
    [Abstract] [Full Text] [Related]

  • 19. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
    Macavei I, Galatâr N.
    Morphol Embryol (Bucur); 1989 Aug 09; 35(2):117-27. PubMed ID: 2529429
    [Abstract] [Full Text] [Related]

  • 20. von Willebrand factor is the most reliable immunohistochemical marker for megakaryocytes of myelodysplastic syndrome and chronic myeloproliferative disorders.
    Chuang SS, Jung YC, Li CY.
    Am J Clin Pathol; 2000 Apr 09; 113(4):506-11. PubMed ID: 10761451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.